About: RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.00 (-9.32%)
RNXTNASDAQRenovoRx Inc
RenovoRx Inc share price
RNXT price activity
Last Price
$2.000
Change (24hr)
-0.21 USD (-9.32%)
Volume
1.72M
Volume (4w avg)
-
Open
$2.15
Day Range
$1.94 - $2.30
Previous Close
$2.20
Last Trade
09 Sep, 8:16 pm GMT+0
Delayed
09 Sep, 8:16 pm GMT+0
RNXT price performance
Delayed
09 Sep, 8:16 pm GMT+0
RNXT Market Signals